News & Insights
Stay up to date with the latest news,health insights, and updates from Ksimg consultants.
June 17, 2026
What Your Heart Rate Says About Your Health: Key Signs
Your heart rate can give useful clues about your overall health, including your fitness level, stress, sleep, hydration, activity level,
June 16, 2026
Prostate MRI Preparation: What To Do Before Your Scan?
Prostate MRI preparation usually means following food, drink, bowel, medicine, and safety instructions before the scan. Good preparation helps the
June 16, 2026
Prostate MRI: What It Shows And When You Need One?
A prostate MRI is a detailed imaging test that helps doctors examine the prostate more clearly. It can support decisions
June 16, 2026
Brello Health: How Long Does It Take To Show Results? Honest Analysis
Pennsylvania, 15 June, 2026. Women looking for weight loss, energy, vitality, and long-term wellness support often want more than a
June 16, 2026
Shockwave Therapy for ED: Benefits, Risks, and What to Know
Shockwave therapy for ED is a non-surgical treatment that uses low-intensity sound waves to support blood flow in the penis.
June 16, 2026
Normal Knee MRI vs Abnormal: What Results Can Mean
A normal knee MRI vs abnormal result shows the difference between healthy-looking knee structures and signs of injury, wear, swelling,
June 16, 2026
Normal vs Abnormal PET Scan: What Results Can Mean
A normal vs abnormal PET scan can help doctors understand how active certain cells and tissues are inside the body.
June 16, 2026
AlzeCure Pharma Reports Positive Phase Ib Results for NeuroRestore ACD856, Strengthening Alzheimer’s Clinical Development Program
STOCKHOLM, Sweden – June 16, 2026. AlzeCure Pharma AB (publ), a clinical-stage biotechnology company focused on developing innovative treatments for
June 16, 2026
Teknova Enhances Digital Research Access Through Bioz Content Hub Integration
PALO ALTO, CA – June 16, 2026. Bioz, Inc., a platform specializing in extracting and delivering insights from peer-reviewed scientific
June 16, 2026
Aplagon Raises EUR 4.8M To Expand Phase 2 Thrombo-Inflammation Program
HELSINKI, Finland – June 16, 2026. Aplagon, a clinical-stage biotechnology company developing APAC, a first-in-class antiplatelet and anticoagulant therapy for